Ecotoxicological Effects of a Commercial Fenthion-Based Formulation on the Survival, Hatching, and Growth of Artemia salina L.: Implications for Risk Assessment in Marine and Estuarine Environments
ACS Omega · 10.11.2026 · 11 (44) · 68679-68695
DOI: 10.1021/acsomega.6c06726 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 27.10.2026. Verfasst von Leonardo Mendes da Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ecologia e Conservação, Universidade Federal de Lavras, 37200-900 Lavras, MG, Brazil. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior, Funda????o de Amparo ?? Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
This present study evaluated the effects of a commercial formulation based on fenthion on survival, hatching, and growth of Artemia salina, and characterized the environmental risk of this insecticide to marine and estuarine ecosystems. The fenthion-based commercial formulation was tested at concentrations ranging from 0.001 up to 731 mg/L using different bioassays: a standard 48-h acute test, a 14-day long-term test, and also two 72-h assays (one for cyst hatching, another for growth inhibition). Obtained EC50 values were fully integrated with available literature data to construct a species sensitivity distribution (SSD) curve, which then determined the hazardous concentration for 5% of species (HC5), the predicted no-effect concentration (PNEC), and the risk quotient (RQ). In the acute assay, the formulation showed low toxicity, with EC50 of 212.36 mg/L at 24 h and 16.64 mg/L at 48 h. In contrast, high toxicity was observed in long-term tests, with EC50 of 0.0752 mg/L after 8 days and 0.0052 mg/L after 14 days of exposure. Minor effects were observed on hatching rate (EC50 = 101.75 mg/L), whereas more pronounced effects were seen on hatching speed (EC50 = 19.88 mg/L) and nauplii growth (EC10 = 0.076 mg/L). The HC5 from the SSD was 0.000104 mg/L, while PNEC was 0.000020 mg/L. The average RQ was 1.86, indicating high risk. Overall, these results demonstrate the ecotoxicological potential of a fenthion-based commercial formulation for relevant organisms in marine and estuarine ecosystems, reinforcing the importance of regulatory measures and environmental monitoring in areas subject to contamination by this insecticide.
Autor:innen und Institutionen
- Departamento de Ecologia e Conservação, Universidade Federal de Lavras, 37200-900 Lavras, MG, Brazil.
ORCID-Profile: Leonardo Mendes da Silva, Larissa Fonseca Andrade-Vieira
Förderung
- Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior
- Funda????o de Amparo ?? Pesquisa do Estado de Minas Gerais
Zitieren
APA
Mendes da Silva, L., Ramos, R. P., Ferreira, J. L., Landim, J. L. F., Magalhães, M. E., & Andrade-Vieira, L. F. (2026). Ecotoxicological Effects of a Commercial Fenthion-Based Formulation on the Survival, Hatching, and Growth of Artemia salina L.: Implications for Risk Assessment in Marine and Estuarine Environments. ACS Omega, 11(44), 68679-68695. https://doi.org/10.1021/acsomega.6c06726
Vancouver
Mendes da Silva L, Ramos RP, Ferreira JL, Landim JLF, Magalhães ME, Andrade-Vieira LF. Ecotoxicological Effects of a Commercial Fenthion-Based Formulation on the Survival, Hatching, and Growth of Artemia salina L.: Implications for Risk Assessment in Marine and Estuarine Environments. ACS Omega. 2026;11(44):68679-68695. doi:10.1021/acsomega.6c06726
BibTeX
@article{MendesdaSilva2026,
author = {Mendes da Silva, Leonardo and Ramos, Rafael Pereira and Ferreira, Joice Lima and Landim, João Lucas Fonseca and Magalhães, Maria Eduarda and Andrade-Vieira, Larissa Fonseca},
title = {Ecotoxicological Effects of a Commercial Fenthion-Based Formulation on the Survival, Hatching, and Growth of Artemia salina L.: Implications for Risk Assessment in Marine and Estuarine Environments},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {44},
pages = {68679--68695},
doi = {10.1021/acsomega.6c06726}
}
EUVIMED